Tufts Center for the Study of Drug Development

7 articles about Tufts Center for the Study of Drug Development

• 

  Tufts' Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure ...

  8/10/2022

  Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts' Ken Getz about possible reasons and solutions.

• Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®

  10/30/2019

  The Tufts CSDD study assessed development cycle times and their financial benefits by using data compiled on completed Translational Pharmaceutics projects to benchmark against industry drug development durations.

• New Oversight Scorecard Dovetails With Benchmark Research On CRO Outsourcing Practices.

  6/18/2019

  Comprehend reveals new solution at DIA 2019, designed for clinical trial process improvement and greater ICH E6(R2) compliance.

• Rising Protocol Complexity Is Hindering Performance while Driving Up Cost of Clinical Trials, According to the Tufts Center for the Study of Drug Development

  7/17/2018

  Rising protocol complexity is hindering clinical trial performance and efficiency, and helping to drive up the cost of developing new drugs, according to a recently completed analysis by the Tufts Center for the Study of Drug Development.

• MSF Scorns Tufts Center (An Affiliate of Tufts University) Study On Cost To Develop Drugs

  11/19/2014

• Tufts Health Plan Named To Top 10 National Health Plans By The National Committee For Quality Assurance

  9/23/2004

• Tufts Health Plan Introduces Health Savings Accounts For Small Business Owners

  9/13/2004